BofA and Goldman Cut Teladoc (TDOC) Price Targets

Core Insights - Teladoc Health, Inc. (NYSE:TDOC) is recognized as one of the best American penny stocks to invest in, with recent price target adjustments from BofA Securities and Goldman Sachs [1][3]. Group 1: Price Target Adjustments - BofA Securities reduced its price target for Teladoc from $7.50 to $7 while maintaining a Neutral rating [1]. - Goldman Sachs also cut its price target from $9 to $8 but retained a Buy rating on the stock [3]. Group 2: User Metrics and Business Segments - BofA noted that BetterHelp's monthly active users in Q4 are 0.2% above Q3 levels but down 18.7% year-over-year, indicating a mixed performance [2]. - Despite the decline in year-over-year metrics, BofA views the quarter-over-quarter flat growth as a positive sign for Teladoc's core Integrated Care business [2]. - There is uncertainty regarding the future growth of both the BetterHelp and Chronic Care segments [2]. Group 3: Company Overview - Teladoc Health is a leading virtual care company providing 24/7 on-demand remote medical care, mental health services, and chronic condition management [4]. - The company facilitates connections between patients and providers for various healthcare needs, including primary care and complex care [4].